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Background: Our objective was to determine the effect of fatty acids (FAs) in serum and follicular fluid (FF) on
fertilization and intracytoplasmic sperm injection (ICSI) outcomes.
Methods: One hundred five women aged 18–38 years undergoing ICSI were recruited in this prospective cohort
study. oocyte and emberyo quality was morphologically assessed. FAs in serum and FF were analyzed, using gas
chromatography–mass spectrometry (GC-MS).
Results: The mean number of mature oocytes was associated with serum levels of oleic acid (r = 0.58; P = 0.002).
There were negative correlations between metaphase II oocytes and FF levels of stearic acid (r = −0.19; P = 0.04) and
linolenic acid (r = −0.37; P = 0.004). According to the obtained Spearman’s correlation coefficients, serum levels of
stearic, palmitoleic and tricosanoic acids were positively correlated with the percent of germinal vesicle (GV) stage
oocyte.
The mean serum level of eicosapentaenoic acid was significantly higher in pregnant women than in non-pregnant
patients (P = 0.006). Good quality embryos’ percentages were negatively correlated with the concentrations of
palmitic acid (r = −0.22; P = 0.02).
After adjusting the effects of body mass index and age, total FAs were found to have a significant effect on the
odds of having high-quality oocytes (percentage of oocytes > 80%; odds ratio =2.55; P = 0.054).
Conclusion: Particular FAs affect oocyte maturation and implantation. Apparently, while higher FF levels of
saturated FAs, especially palmitic and stearic acids, observed in some metabolic contexts have harmful effects on
oocyte maturation and implantation, such effects can be counteracted and developmental competence can be
enhanced (at least in vitro) by the presence of unsaturated FAs, e.g. oleic and eicosapentaenoic acids.
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Fatty acids (FAs), commonly classified a saturated (SFA),
monounsaturated (MUFA), and polyunsaturated (PUFA),
play an important role in oocyte maturation and embryo
development [1, 2]. While many studies have evaluated
the effects of FAs on oocyte maturation and early em-
bryo development in animals, little is known about the
effects of FAs on human fertility [2–6]. According to
previous animal and human studies, similar FAs are
found in the FF and blood serum. However, follicular* Correspondence: fatemehzahra_86@live.com; sesmael@yahoo.com
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The most common FAs in animal and human FF are
oleic, palmitic, and stearic acids [8] and palmitic, oleic,
and linoleic acids, respectively [1]. Animal model studies
have reported relations between SFAs, such as palmitic
and stearic acids, and decreased rates of fertilization,
cleavage, and blastocyst formation. These FAs inhibit
granulosa and theca cell proliferation and induce apop-
tosis. On the contrary, arachidonic acid has a protective
effect on granulosa cells [4, 8, 9]. Unsaturated FAs, such
as oleic acid, enhanced blastocyst formation, oocyte mat-
uration and embryo development [1, 9]. In fact, oleic
acid can compensate for the negative effects of palmiticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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do not have any negative effects and can even improve
post-fertilization developmental competence [10]. In a
study on pigs, the most common FAs found in immature
pig oocytes were palmitic and oleic [11].
Linoleic acid and alpha-linoleic acid are two PUFAs,
which can be both found in plants and plant oils, are
particularly important in daily diet. Haggarty et al. de-
tected significantly higher levels of linoleic acid in em-
bryos which developed beyond the four-cell stage and
concluded that this acid played a significant role in a
number of key embryo development processes [12]. A
correlation between linoleic acid and fertility rates was
also documented in another study [13]. However, other
studies argued that high levels of linoleic acid negatively
affected oocyte maturation and developmental compe-
tence in animal models [9, 14]. It has also been found to
exert a damaging effect on human reproductive system
and decrease the chance of pregnancy after in vitro
fertilization [15].
Since the majority of previous studies focused on animal
models and reported controversial results about the effects
of serum and follicular fluid FAs on oocyte maturation
and post-fertilization developmental competence, this
study evaluated associations between serum and follicular
fluid concentrations of FAs and oocyte quality, embryo de-
velopment, and pregnancy rate in women who underwent
intracytoplasmic sperm injection (ICSI).
Methods
Patients
From March 2015 to July 2015 a total of 105 women,
22–38 years of age, who undergone ICSI and embryo
transfer at Fatemeh Zahra Infertility and Reproductive
Health Research Center, Babol University of medical sci-
ences, Iran, were included in the study.
Oocyte retrieval
All patients had a transvaginal ultrasound (TVS) on the
third day of menstruation (5 MHz probe Fokuda, Japan)
to rule out ovarian cysts. Following ovarian suppression
by the subcutaneous injection of 0.1 mg gonadotropin re-
leasing hormone analog (triptorelin, Diphereline, Ipsen-
Pharma Biotech, France) from the midluteal phase of the
preceding cycle, controlled ovarian stimulation was started
with a dose of 75–150 IU recombinant human follicle
stimulating hormone (rFSH, 75 IU GONAL-f, Merck
Serono, Germany) (HMG, Fostimon75 IU/Ampule IBSA,
Switzerland) were given daily until the average diameter of
the leading follicle reached 18–20 mm. Then Intramuscu-
lar HCG (Karma, Germany) at a dose of 10,000 IU was ad-
ministered. Under ultrasound guidance, oocyte retrieval
was performed 36 h after HCG administration. Sample of
venous blood was collected on the day of oocyte retrieval.Collected oocytes according to their morphology, were
classified into three grades; Metaphase II (MII), metaphase
I (MI) and Germinal vesicles (GV) [16]. After removal of
the oocyte, FF and coagulated blood were immediately
centrifuged (1000 g, min) and stored at −80 °C until
analysis.
Retrieved oocytes were fertilized by ICSI and cultured
until the blastocyst stage. Embryos with, little or no frag-
mentation, and a zona pellucida that is not extremely
thick or dark in appearance were classified as Grade A,
embryos with equally-sized blastomeres, minor cyotplas-
mic fragmentation covering ≤ 10% of the embryo surface
Grade-B and blastomeres of distinctly unequal size and
moderate-to-significant cytoplasmic fragmentation cov-
ering >10% of the embryo surface Grade C.
A written consent was obtained from each patient for
the use of FF and the study design was approved by the
Ethical Review Committee of Babol University of Medical
Sciences.
Clinical pregnancy was confirmed if gestational sac
and fetal pole were visualized 7 weeks later.
Extraction method
Serum and follicular fluid samples (1.5 ml each) were
shaken on a platform vortexer for three minutes. After
ward, 3 ml ice-cold acetone (Fluka, Buchs, Switzerland)
were added to the samples to precipitate plasma pro-
teins. The samples were then vortexed again for several
seconds and maintained at −20 °C for 15 min. After the
centrifugation of the precipitated proteins (Universal
2S Centrifuge, Hettich Lab Technology, Germany), the
supernatant was separated and added with 3-ml ali-
quots of hexane (Fluka, Buchs, Switzerland) and water.
The samples were then securely closed with Teflon-
lined caps and shaken gently in a horizontal platform
shaker for 5 min. Centrifugation was then performed
to separate the solvent and the aqueous phases. The
upper phase (hexane) was transferred into sterile tubes.
A 0.25 ml aliquot of buffer, containing 0.2 M dibasic
potassium phosphate with a pH of 9.0 and tri basic po-
tassium phosphate (Sigma-Aldrich, USA) and 0.25 ml
iodomethane (Fluka, Buchs, Switzerland) in dichloro-
methane (1:10 vol:vol) were added and the samples
were vortexed for 5 min to form the free acid methyl
esters (FAME). FAs of the samples were then separated
and identified through capillary gas chromatography
using an HB5column (dimensions: 30 m, 0.25 mm, and
0.25 μm) installed in a headspace gas chromatography/
mass spectrometry device (Agilent technology GC
7890 and Mass 5975 detector).
Standard samples of FAs were obtained from
Merck (Darmstadt, Germany) and the FAME stand-
ard (C4-C24) was purchased from Supelco (Sigma-
Aldrich, USA).
Table 1 Clinical characteristic’s of sampled patients
Mean ± SD
n (%)
Age (year) 31 ± 6
BMI (kg/m2) a 27.08 ± 4.2





Male factor 41 (39%)










Sperm count (106/ml) 48.54 ± 39
Sperm Motility (%) 2.1 ± 1.01
FSH (mlu/ml) 7.5 ± 3.5
LH (mlu/ml) 7 ± 6.53
Prolactin (ng/ml) 23 ± 2.6
No. oocyte Oocyte quality 9 ± 5.6
MII 79% ± 30%
MI 9% ± 18%
GV 4% ± 13%
No. Embryo 4.38 ± 4%
No. embryos/No. oocytes 51% ± 27%
No. good quality embryos/No. embryo 85% ± 22%
No. good embryo/No. oocytes 43% ± 27%
Clinical pregnancy n (%) 29 (27.6%)
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Reagents and materials
All the solutions were prepared using reagent-grade che-
micals and deionized-distilled water. The standard FAME
samples (oleic, stearic, palmitic, palmitoleic, myristic, ara-
chidonic eicosapetaenoic (EPA), tricosanoic, docosahexae-
noic (DHA) and linoleic methyl esters) were obtained
from Supelco Inc. (Sigma-Aldrich, USA). The derivatiza-
tion reagent was iodomethane (Sigma-Aldrich, USA). The
phosphate buffer (pH = 9.0) was prepared by mixing 0.1
MNa3PO4 and 0.1 M Na2HPO4 (both from Sigma-
Aldrich, USA) in water. Hexane and dichloromethane
were obtained from Merck (Darmstadt, Germany).
Apparatus
Quantitative GC-MS analysis was determined by using a
GC: Agilent7890 and MS: Agilent5975c (with an
HB5column). A model 220 Corning pH meter was used
to carry out the pH measurements. Centrifugation was
carried out by Hettich (Model Universal2S)
Results
Of the 119 women initially considered for inclusion in the
study, four had only one growing follicle and no oocytes to
be retrieved and 10 had no chance of carrying a viable em-
bryo. Therefore, 105 women were finally included in the
study. Table 1 shows the baseline characteristics, basal
hormone profile and reproductive outcomes of the partici-
pants. Correlation analysis revealed strong relationships
between serum and follicular fluid levels of myristic acid
(r = 0.63; P < 0.001), linolenic acid (r = 0.52; P = 0.001), and
linoleic acid (r = 0.44; P = 0.003). However, the correlations
between serum and follicular fluid levels of palmitoleic
acid (r = 0.2; P = 0.03), EPA (r = 0.18; P = 0.06), DHA
(r = 0.23; P = 0.02), and arachidonic acid (r = 0.22; P = 0.03)
were weak. No significant correlations were found between
serum and follicular fluid levels of palmitic acid (r = 0.12;
P = 0.21), stearic acid (r = 0.12; P = 0.19), oleic acid (r = 0.06;
P = 0.49), caproic acid (r = 0.12; P = 0.54) and tricosanoic
acid (r = 0.02; P = 0.79).
Figures 1, 2, and 3 show the output from a GC/MS
instrument for the peak in the chromatogram. As
seen in Table 2, the mean number of mature oocytes
was associated with serum levels of oleic acid (r =
0.58; P = 0.002). Moreover, there were negative correla-
tions between metaphase II (MII) oocytes and follicular
fluid levels of stearic acid (r = −0.19; P = 0.04) and linolenic
acid (r = −0.37; P = 0.004). According to the obtained
Spearman’s correlation coefficients, serum levels of
palmitoleic and tricosanoic acids were positively cor-
related with the percent of germinal vesicle (GV)
stage oocytes (Table 2).
Table 3 compares the mean follicular fluid and serum
concentrations of FAs in pregnant and non-pregnantwomen. Student’s t-test results showed a significant differ-
ence between follicular fluid concentration of palmitic
acid in pregnant and non-pregnant women (P = 0.02). In
addition, the mean serum level of EPA c acid was signifi-
cantly higher in pregnant women than in non-pregnant
patients (P = 0.006). Good quality embryos’ percentages
(2B and 4A) were negatively correlated with the concen-
trations of palmitic (r = −0.22; P = 0.02).
A receiver operating characteristic (ROC) curve analysis
was conducted to determine the level of follicular fluid FA
which best predicted reduced oocyte quality (defined as
Table 2 Assessment of follicular fluid and serum fatty acids with the outcome of pregnancy
Fatty acid (ppm) No. oocyte MII MI GV Good embryo
Follicular Fluid fatty acids Palmitic (C16:0) −0.4 (0.69) −0.01 (0.89) −0.003 (0.97) 0.07 (0.44) 0.08 (0.39)
Palmitoleic (C16:1) 0.11 (0.24) 0.05 (0.61) −0.06 (0.53) 0.02 (0.80) 0.04 (0.68)
Stearic (C18:0) 0.08 (0.4) −0.19 (0.04) −0.08 (0.39) 0.10 (0.28) 0.03 (0.77)
Myristic (C14:0) −0.04 (0.64) −0.04 (0.66) 0.03 (0.71) 0.07 (0.43) 0.02 (0.80)
Oleic (C18:1) −0.43 (0.66) 0 (0.98) 0.07 (0.45) 0.09 (0.32) −0.02 (0.81)
linolenic (C18:3) −0.14 (0.27) −0.37 (0.004) 0.04 (0.075) 0.12 (0.33) −0.06 (0.63)
Linoleic (C18:2) −0.04 (0.65) −0.01 (0.90) −0.02 (0.81) 0.09 (0.35) 0.02 (0.81)
Arachidonic (C20:4) 0.16 (0.13) 0.02 (0.81) −0.03 (0.72) 0.05 (0.63) −0.11 (0.33)
Caproic (C6: 0) −0.18 (0.35) 0.04 (0.81) 0.03 (0.87) −0.09 (0.64) 0.16 (0.4)
EPA (C20:5) 0.10 (0.30) 0.05 (0.61) −0.03 (0.75) −0.10 (0.30) 0.05 (0.56)
Tricosanoic (C23:0) 0.04 (0.65) 0.05 (0.58) −0.03 (0.76) −0.04 (0.66) 0.05 (0.60)
DHA (C22:6) 0.05 (0.64) 0 (0.93) −0.05 (0.62) 0.13 (0.23) −0.04 (0.70
Serum fatty acids Palmitic (C16:0) 0.07 (0.45) 0.12 (0.23) 0.14 (0.142) 0.16 (0.88) −0.009 (0.93)
Palmitoleic (C16:1) 1.01 (0.67) −0.14 (0.15) 0.02 (0.71) 0.28 (0.005) −0.01 (0.90)
Stearic (C18:0) −0.09 (0.37) −0.09 (0.35) −0.05 (0.59) 0.31 (0.002) 0.02 (0.80)
Myristic (C14:0) −0.06 (0.54) −0.02 (0.79) 0.10 (0.31) 0.06 (0.54) 0.03 (0.76)
Oleic (C18:1) 0.58 (0.002) 0.07 (0.45) −0.06 (0.53) −0.04 (0.72) 0.07 (0.50)
linolenic (C18:3) −0.15 (0.25) 0.05 (0.68) −0.04 (0.74) 0.13 (0.33) 0.01 (0.90)
Linoleic (C18:2) −0.04 (0.67) 0.13 (0.19) −0.10 (0.29) −0.06 (0.50) 0.11 (0.28)
Arachidonic (C20:4) −0.16 (0.88) 0.12 (0.26) −0.10 (0.35) −0.04 (0.65) 0.12 (0.26)
Caproic (C6: 0) −0.06 (0.42) 0.13 (0.49) −0.008 (0.97) −0.17 (0.40) −1 (0.63)
EPA (C20:5) −0.02 (0.77) 0.01 (0.84) 0.04 (0.64) −0.05 (0.59) 0.06 (0.54)
Tricosanoic (C23:0) 0.01 (0.89) −0.10 (0.31) −0.003 (0.97) 0.24 (0.014) −0.14 (0.16)
DHA (C22:6) −0.08 (0.43) 0.10 (0.35) −0.10 (0.36) −0.01 (0.91) 0.11 (0.32)
Values are reported as Correlation coefficient (P-value)
Table 3 Assessment of follicular fluid and serum FFAs level in pregnant and non pregnant women
Fatty acid Serum Follicular fluid
Pregnancy positive Pregnancy negative P-value Pregnancy positive Pregnancy negative P-value
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Palmitoleic (C16:1) 29 ± 22.1 28.7 ± 22 0.96 42.3 ± 13.4 25.64 ± 2 0.35
Stearic (C18:0) 39.12 ± 23.3 24.12 ± 16.5 0.36 12 ± 8.5 19 ± 12.2 0.43
Myristic (C14:0) 4.72 ± 4 4.22 ± 4 0.54 3.02 ± 3.5 2.95 ± 3.3 0.92
Oleic (C18:1) 188.26 ± 83 31.58 ± 65 0.32 18.14 ± 25.3 27 ± 54.04 0.41
Palmitic (C16:0) 19 ± 47 34.44 ± 17.2 0.28 11 ± 9.3 25.38 ± 14 0.02
linolenic (C18:3) 6.33 ± 4.2 6 ± 4 0.87 5.59 ± 4 6 ± 6.50 0.87
Arachidonic (C20:4) 54.45 ± 16 44.58 ± 15 0.79 13.60 ± 48 14 ± 38.5 0.99
Linoleic (C18:2) 48.54 ± 14 42.44 ± 140 0.84 19 ± 45 30.08 ± 10 0.57
Caproic (C6: 0) 93.16 ± 13.6 56 ± 134 0.55 37.33 ± 85 31 ± 7.9 0.83
EPA (C20:5) 23.06 ± 18 15.68 ± 9 0.006 21 ± 2.6 18.37 ± 9 0.61
Tricosanoic (C23:0) 15.33 ± 6.01 14.42 ± 6 0.49 40 ± 131 18 ± 33.3 0.38
DHA (C22:6) 101.09 ± 26 107.5 ± 339 0.93 53.5 ± 135 78 ± 16 0.52
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AUC for total FA in detecting patients with low quality ver-
sus high quality oocytes was 0.62 (95% confidence interval:
(0.51–0.74); P = 0.048; Fig. 4).
The optimal cut-off point for total FAs was 1.63 with a
sensitivity and specificity of 55 and 62%, respectively.
After adjusting the effects of body mass index (BMI) and
age in logistic regression, total FAs (<1.63 and >1.63)
were found to have a significant effect on the odds of
having high-quality oocytes which was defined as
patients with more than 80% of good oocytes; odds
ratio =2.55; P = 0.054).
Discussion
This study aimed to investigate the effects of serum and
follicular fluid concentrations of FAs on the ICSI outcome.
Since serum plays a major role in the composition of FF,
metabolic changes in serum can alter the biochemical
compounds of the FF. Follicle maturation is, hence, af-
fected by blood metabolite concentrations. Several studies
have shown that most serum FAs are reflected in the fol-
licular fluid composition, but at lower levels [2, 17, 18].
The results of this study showed a positive correlation
between FF and blood serum concentrations of PUFAs,
such as linolenic and linoleic acids, which are essential FAsFig. 1 The GC/MS chromatogram of the fatty acid methyl estersthat cannot be synthesized by the body. On the other hand,
no significant relationship was found between serum and
follicular fluid concentrations of SFAs, including palmitic,
stearic, and caproic acids. Likewise, Jungheim et al. could
not establish a significant relationship between serum and
FF concentrations of palmitic and stearic acids [19].
The pregnancy rate in this study, i.e. 27.6%, was lower
than that reported in previous studies [7, 15]. ICSI failed
in a number of our patients although they had high-
quality oocytes and normal hysteroscopy results. Since
serum levels of FAs are directly related to food intake
and adiposity [20] the low success rate of ICSI might
have been caused by the nutrition status and lifestyle of
the patients (most patients in this study were actually
overweight and their mean BMI was 27.08 ± 4.21 kg/m2).
Another common cause of ICSI failure is reduced endo-
metrial receptivity. The role of FAs as energy providers
in decidualization has been shown in many studies. FAs
and the β-oxidation pathway have been shown to be crit-
ical for oocyte growth and differentiation and embryo
implantation [21, 22]. However, limited data is available
about the relationship between FA metabolism and hu-
man embryo differentiation and implantation.
Most previous animal studies have evaluated bovine
levels of FAs. Humans and Bovine usually ovulate a
Fig. 2 Typical output of GC/MS instrument separation of methyl esters substituted fatty acids in the follicular fluid sample
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due to the similarities between human and bovine ovar-
ian function and oocyte characteristics, the Bovine can
be an excellent model for human reproductive system
studies. According to animal studies, the early embry-
onic development is associated with higher complexity
of FAs, especially an elevation in arachidonic acid levels
[23, 24]. However, comparisons between human andFig. 3 The output from a GC/MS instrument for the peak in the chromatog
at the retention time of 35.506 min. The lower plot is the computer recons
acid, methyl esteranimal oocytes showed the concentrations of oleic and
linoleic acids in early stage human embryos to be respect-
ively one-third and half those in animal oocytes. There-
fore; further studies are required to directly examine the
role of fat metabolism in the development of human em-
bryos and the quality of embryos. In a human study,
Haggarty et al. [12] Showed significantly higher levels of
linoleic and oleic acids and a lower concentration of totalram. The upper curve corresponds to the mass spectra of the sample
tructed mass spectra from the instrument library for hexadecanoic
Fig. 4 ROC curve for Total fatty acid in discriminating patients with
poor quality oocytes from those with good quality
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cell stage. They also found higher concentrations of ara-
chidonic and DHA in the later stages of development.
These results are consistent with the data presented
here which indicated not only positive correlations be-
tween oleic and EPA and oocyte maturation and im-
plantation, but also a negative correlation between
stearic acid and MII oocytes. We also detected signifi-
cantly positive correlations between the concentrations
of stearic, palmitoleic, and tricosanoic acids and imma-
ture (GV) oocytes. Although FAs are important in oo-
cyte differentiation and embryo implantation, their high
levels might have an adverse effect on the reproductive
outcome. Previous animal model studies have demon-
strated that the concentrations of FAs (i.e. SFAs,
MUFAs, and PUFAs) in the follicular fluid and a fat-rich
diet affected the developmental competence and
fertilization potential of oocytes and thus embryo devel-
opment. However, there have been contradictory results
in this regard.
Several reports have shown that saturated FAs, such as
palmitic and stearic acids, had an adverse effect on oo-
cyte quality. Several in vitro and in vivo animal studies
have documented the inhibitory effects of stearic and
palmitic acids on early cleavage and number of oocytes
reaching the blastocyst stage. They have reported that
the capacity of cleaved zygotes to become blastocysts
was lower in higher levels of stearic acid. In fact, high
levels of stearic acid increased both amino acid metabol-
ism and nuclear fragmentation which in turn caused
higher apoptotic cell ratio and DNA damage [25–27].
Jungheim et al. concluded that moderate levels of
palmitic acid decreased cell proliferation and the num-
ber of cells in the inner cell mass and increased the
apoptosis of trophoblast stem cells [3]. Consistent re-
sults were reported in a study on human granulosa cells
where palmitic and stearic acids impaired fertility bysuppressing human granulosa cell survival and inducing
apoptosis [28].
In contrast the findings of this study and previous
research, some researchers highlighted the vital role
and beneficial effects of palmitic acid on oocyte mat-
uration [29, 30].
Our most interesting finding was the negative effect of
linolenic acid on oocyte maturation. Although this find-
ing is inconsistent with the results of some published
studies [31, 32], it is in agreement with those of some
others indicating the role of linolenic acid in inhibiting
the development of the oocytes to the MII stage and cu-
mulus cell expansion [33, 34].
Linolenic acid is an essential omega-3 FA obtained
from foods such as vegetable oils, flaxseed, and soy seed.
It is called “essential” because it is needed for cell growth
and differentiation [15]. Despite the positive role of poly
unsaturated fat intake in health status, we observed ele-
vated linolenic acid levels to be strongly correlated with
the number of oocytes retrieved, but not with the ICSI
outcome. Therefore, this fatty acid could be considered
as a marker of ovarian response, but not of oocyte or
embryo quality.
Another important finding of this study was the sig-
nificant positive correlation between serum oleic acid
levels and number of retrieved oocytes. Oleic acid is a
MUFA critical for oocyte maturation. It can overcome
the adverse effects of palmitic and stearic acids.
We also found the mean concentration of SFAs (pal-
mitic and stearic acids) to be higher (but not signifi-
cantly) in women with polycystic ovary syndrome
(PCOS). Approximately half of our participants with
PCOS were overweight. Previous studies have argued
that obesity and food intake might contribute to serum
and follicular fluid FA concentrations. Therefore, all of
patients with PCOS should be referred to a nutritionist
before the ICSI procedure. Meanwhile, we did not detect
any differences in follicular fluid and serum levels of FAs
between patients with and without endometriosis. Since
only 13 women with PCOS and four women with endo-
metriosis participated in our study, studies with larger
sample size are required to confirm these findings.
NIU et al. determined plasma and follicular fluid FA
contents of 55 patients with PCOS and concluded that
oocyte development, degree of embryo fragmentation,
and pregnancy outcomes were positively correlated with
the plasma and follicular fluid levels of stearic and oleic
acids [35]. Khanaki et al. found that the mean level of
stearic acid was significantly lower in patients with
endometriosis. Furthermore, the ratio of EPA to arachi-
donic acid was correlated with the severity of endometri-
osis [36]. Jungheim et al. reported higher levels of
follicular fluid FAs in patients with endometriosis but
they concluded that oocyte quality was mostly affected
Mirabi et al. Lipids in Health and Disease  (2017) 16:18 Page 8 of 9by aberrations in FA metabolism or dietary FA intake ra-
ther than endometriosis. They suggested modifications
in the types of consumed fats in these patients [37]. An-
other study showed an association between trans-
unsaturated fat consumption and incidence of endomet-
riosis [29]. Further studies with larger sample size are,
hence, required to assess the correlations of serum and
follicular fluid levels of FAs with diet and severity of
endometriosis among infertile women.
A limitation of this study was not considering the nu-
tritional habits and adiposity and values of oxidant and
antioxidant enzymes of our participants.
The prospective design and comparing both serum
and follicular fluid levels of FAs with ICSI outcome were
the major strengths of our study.
The findings raise salient questions for future research.
In fact, further studies are warranted to clarify whether
or not changes in diet and body weight alter serum and
follicular fluid levels of FAs and consequently affect the
assisted reproductive outcomes. Moreover, researchers
are recommended to examine whether the total FA con-
tent could be used as a marker for determining the
number of mature oocytes and quality of embryos.Conclusion
Particular FAs affect oocyte maturation and implant-
ation. Apparently, while higher follicular fluid levels of
SFAs, especially palmitic and stearic acids, observed in
some metabolic contexts have harmful effects on oocyte
maturation and implantation, such effects can be coun-
teracted and developmental competence can be en-
hanced (at least in vitro) by the presence of unsaturated
FAs, e.g. oleic acid and eicosapentaenoic acids.
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